Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Eye & Contact Lens-Science and Clinical Practice, published by Lippincott Williams & Wilkins, stands as a premier journal in the fields of ophthalmology and contact lens research. With an ISSN of 1542-2321 and an E-ISSN of 1542-233X, this journal serves as a vital resource for researchers, clinicians, and students dedicated to the study and application of eye care practices. Maintaining a distinguished impact factor within the Q2 category of Medicine and Ophthalmology as of 2023, it ranks impressively at #33 among 137 journals, placing it in the top 76th percentile according to Scopus metrics. Since its inception in 1986, Eye & Contact Lens has consistently delivered cutting-edge research and clinical insights, facilitating advancements in therapeutic techniques for contact lens wear and ocular health. Though not an Open Access journal, it remains accessible through institutional subscriptions, ensuring that essential findings are shared among professionals in the field. The objective of the journal is to present high-quality, peer-reviewed articles that advance the science and practice of eye care, making it an indispensable tool for those seeking to enhance their knowledge and contribute to this dynamic discipline.

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

The Journal of Pediatric Ophthalmology & Strabismus, published by SLACK INC, is an esteemed academic journal dedicated to the field of pediatric ophthalmology and strabismus. Since its inception in 1978, this journal has continuously provided a vital platform for the dissemination of innovative research, clinical practices, and advancements in the understanding of eye conditions affecting children. With an impressive two Q2 quartile ranking in Medicine, Ophthalmology, and Pediatrics as of 2023, the journal underscores its significance in contributing to the medical community by fostering scholarly dialogue and knowledge exchange. While not an open-access journal, it offers a comprehensive set of articles aimed at enhancing the diagnostic and therapeutic approaches available to practitioners in the field. Researchers, clinicians, and students alike will benefit from its rigorously peer-reviewed content, which aims to improve pediatric eye care and promote better health outcomes for children. Join the discourse that shapes the future of pediatric ophthalmology!

International Ophthalmology is a prestigious journal published by Springer, dedicated to advancing the field of ophthalmology through the dissemination of high-quality research and clinical studies. With an ISSN of 0165-5701 and an E-ISSN of 1573-2630, this journal has been a vital resource since its inception in 1978, serving the global community of ophthalmologists, researchers, and healthcare professionals. The journal holds a significant Q2 ranking in the category of ophthalmology and has achieved a commendable position as #56 in Scopus's rankings, placing it within the top tier of its field. Although it does not offer open-access options, articles published in International Ophthalmology are widely cited and respected, playing a crucial role in the ongoing dialogue regarding contemporary ophthalmic practices and innovations. With a broad scope covering all aspects of eye care, this journal is essential for those aiming to keep abreast of the latest developments and research findings that shape the future of vision science and clinical practice.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.